Geldanamycin derivatives and neuroprotective effect on cultured P19-derived neurons.
Basic Information
ID: ALA1139942
Journal: Bioorg Med Chem Lett
Title: Geldanamycin derivatives and neuroprotective effect on cultured P19-derived neurons.
Authors: Tadtong S, Meksuriyen D, Tanasupawat S, Isobe M, Suwanborirux K.
Abstract: Geldanamycin (1), an antifungal and anticancer ansamycin, was reported as a neurotrophic and neuroprotective substance against antineoplastic drugs, paclitaxel, vincristine, and cisplatin, on cultured dorsal root ganglion neurons from chick embryos. In this study, 1 in a large quantity, together with a known 17-O-demethylgeldanamycin (2), and a new 17-O-demethylgeldanamycin hydroquinone (3) were obtained from a mangrove Streptomyces sp. A series of O-alkyl and N-alkyl derivatives of 1 were prepared by modification of C-17 and/or C-19 on the quinone ring and were evaluated for in vitro activity against P19-derived neurons. Compound 1 and 19-O-methylgeldanamycin (7) at a very low dose (1nM) enhanced survival and neurite outgrowth of P19-derived neurons and prevented neurotoxicity of paclitaxel and vinblastine. Compound 7, possessing the lowest cytotoxicity and neurotoxicity, is serving as the most promising candidate in neurodegenerative therapy against neurotoxic anticancer drugs.
CiteXplore: 17442565
DOI: 10.1016/j.bmcl.2006.12.041
Patent ID: ┄